首页 | 本学科首页   官方微博 | 高级检索  
     

嗅鞘细胞移植治疗慢性脊髓损伤的临床研究进展
引用本文:温 俭,王岩松,魏 利,李 杰. 嗅鞘细胞移植治疗慢性脊髓损伤的临床研究进展[J]. 中国组织工程研究, 2013, 17(19): 3581-3588. DOI: 10.3969/j.issn.2095-4344.2013.19.025
作者姓名:温 俭  王岩松  魏 利  李 杰
作者单位:1哈尔滨医科大学附属第二医院脊柱外科,黑龙江省哈尔滨市 1500862哈尔滨医科大学附属第二医院急诊创伤科,黑龙江省哈尔滨市 1500863哈尔滨医科大学附属第二医院神经内科,黑龙江省哈尔滨市 150086
基金项目:国家自然科学基金资助项目(30800260)
摘    要:背景:虽然迄今为止大量的体外和动物实验都证实了嗅鞘细胞对脊髓损伤的修复作用,但是利用嗅鞘细胞移植治疗脊髓损伤的临床试验尚处于起步阶段。目的:观察嗅鞘细胞移植治疗慢性脊髓损伤的临床安全性、有效性及实用性。方法:由第一作者检索至2012年5月为止 PubMed数据及CNKI中国期刊全文数据库有关嗅鞘细胞移植治疗慢性脊髓损伤的临床试验研究及安全性、疗效方面相关的报道,以“olfactory ensheathing cells, spinal cord injury, clinical research”为英文检索词,“嗅鞘细胞移植,脊髓损伤”为中文检索词。结果与结论:计算机初检得到133篇文献,阅读标题和摘要进行初筛,排除重复性研究,共34篇文献符合纳入标准。结果显示,利用嗅鞘细胞移植治疗脊髓损伤,在体外试验和动物模型中获得了良好的效果。在临床试验方面,到目前为止,嗅鞘细胞病灶直接移植治疗慢性脊髓损伤按嗅鞘细胞来源分主要集中在以下几个方面:①胚胎嗅鞘细胞移植。②嗅黏膜移植。③嗅黏膜源性嗅鞘细胞移植。3种嗅鞘细胞移植方法的总体安全性(96.4%)和有效性(23.4%)较高,但是其移植方法均存在明显的不足。提示嗅鞘细胞移植治疗慢性脊髓损伤的安全性和有效性还需要进一步验证,转化为临床应用还有很长的路要走。

关 键 词:干细胞  干细胞学术探讨  嗅鞘细胞  脊髓损伤  慢性脊髓损伤  细胞移植  安全性  有效性  国家自然科学基金  
收稿时间:2012-09-10

Clinical progress in olfactory ensheathing cell transplantation for treatment of chronic spinal cord injury
Wen Jian,Wang Yan-song,Wei Li,Li Jie. Clinical progress in olfactory ensheathing cell transplantation for treatment of chronic spinal cord injury[J]. Chinese Journal of Tissue Engineering Research, 2013, 17(19): 3581-3588. DOI: 10.3969/j.issn.2095-4344.2013.19.025
Authors:Wen Jian  Wang Yan-song  Wei Li  Li Jie
Affiliation:1 Department of Spine Surgery, Second Hospital of Harbin Medical University, Harbin  150086, Heilongjiang Province, China
2 Department of Emergency and Trauma, Second Hospital of Harbin Medical University, Harbin  150086, Heilongjiang Province, China
3 Department of Neurology, Second Hospital of Harbin Medical University, Harbin  150086, Heilongjiang Province, China
Abstract:BACKGROUND:A large number of in vitro and animal experiments have demonstrated the effects of olfactory ensheathing cells in the repair of spinal cord injury, but the clinical studies regarding olfactory ensheathing cell transplantation for the treatment of spinal cord injury are in infancy.OBJECTIVE: To investigate the clinical safety, efficacy and practicality of the olfactory ensheathing cell transplantation for treatment of chronic spinal cord injury.METHODS:Using “olfactory ensheathing cells, spinal cord injury, clinical research” as keywords, the first author retrieved PubMed databases and CNKI database for papers regarding clinical studies on olfactory ensheathing cell transplantation for treatment of chronic spinal cord injury as well as clinical safety and effectiveness published before May 2012.RESULTS AND CONCLUSION: A total of 133 papers were initially retrieved. After reading titles and abstracts, repetitive studies were excluded and 34 papers were included in the final analysis. Olfactory ensheathing cell transplantation for spinal cord injury has acquired good efficacy in in vitro and animal experiments. In the clinical trials, there are several sources of olfactory ensheathing cells used in treatment of chronic spinal cord injury: (1) embryonic olfactory ensheathing cell transplantation; (2) olfactory mucosa transplantation; (3) olfactory mucosa-derived olfactory ensheathing cell transplantation. The oval safety and efficacy of three kinds of olfactory ensheathing cell transplantation methods are 96.4% and 23.4%, respectively, but there are obvious limitations. These findings suggest that the safety and efficacy of olfactory ensheathing cell transplantation in the treatment of chronic spinal cord injury need further investigation and there is a long road ahead for clinical application.
Keywords:stem cells  stem cell academic discussion  olfactory ensheathing cells  spinal cord injury  chronic spinal cord injury  cell transplantation  safety  efficacy  National Natural Science Foundation of China  
点击此处可从《中国组织工程研究》浏览原始摘要信息
点击此处可从《中国组织工程研究》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号